RedHill Biopharma (RDHL) EBITDA Margin Growth (5y) (2017 - 2023)
Powered by 
Analysis
RedHill Biopharma (RDHL) EBITDA Margin Growth (5y) (2017 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 10.63 Mn | 10.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 258,619.00 |
| Mar 31, 2023 | -121,680.00 |
| Dec 31, 2022 | -130,975.00 |
| Sep 30, 2022 | -87,644.00 |
| Jun 30, 2022 | -275,318.00 |
| Jun 30, 2021 | -71.93 Mn |
| Jun 30, 2020 | -58.89 Mn |
| Mar 31, 2020 | -47.39 Mn |
| Dec 31, 2019 | -48.07 Mn |
| Sep 30, 2019 | -12.46 Mn |
| Jun 30, 2019 | -10.21 Mn |
| Mar 31, 2019 | 48,340.00 |
| Dec 31, 2018 | -34.73 Mn |
| Sep 30, 2018 | 9.21 Mn |
| Jun 30, 2018 | 6.36 Mn |
| Mar 31, 2018 | 5.08 Mn |
| Dec 31, 2017 | 5.36 Mn |
| Sep 30, 2017 | 6.51 Mn |
| Jun 30, 2017 | -3.85 Mn |